FIRST-LINE THERAPY

Clinical trials for FIRST-LINE THERAPY explained in plain language.

Never miss a new study

Get alerted when new FIRST-LINE THERAPY trials appear

Sign up with your email to follow new studies for FIRST-LINE THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1

New drug combo aims to shrink esophageal tumors

Disease control Not yet recruiting

This study tests a new drug called QL1706, which helps the immune system fight cancer, combined with two chemotherapy drugs (nab-paclitaxel and cisplatin) as a first treatment for people with advanced or spread esophageal cancer. About 50 adults who have not had prior treatment f…

Matched conditions: FIRST-LINE THERAPY

Phase: PHASE2 • Sponsor: The First Affiliated Hospital of Henan University of Science and Technology • Aim: Disease control

Last updated May 04, 2026 16:21 UTC

FIRST-LINE THERAPY

Get alerted when new FIRST-LINE THERAPY trials appear

New drug combo aims to shrink esophageal tumors